Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
06/2010
06/01/2010US7727551 Oral pharmaceutical compositions with modified release of the active ingredient
06/01/2010US7727549 Otic compositions are disclosed. The compositions contain an otic drug and a carrier comprising a low molecular weight compound. The compositions do not drain out of the ear after administration.
06/01/2010US7727546 Nutrient system for individualized responsive dosing regimens
06/01/2010US7727543 Biodegradable carrier and method for preparation thereof
06/01/2010US7727541 Medical devices having polymeric regions based on vinyl ether block copolymers
06/01/2010US7727538 Methods and compounds for the treatment of mucus hypersecretion
06/01/2010US7727537 Stabilized compositions for topical administration and methods of making same
06/01/2010US7727524 Low sodium liquid seasoning with anti-hypertensive activity
06/01/2010US7727512 Nanoparticle emulsion in perfluorohydrocarbon solvent; chelating agents coupled, optionally through a spacer, to phosphoglyceride; magnetic resonance imaging; excretion of toxic paramagnetic ion
06/01/2010US7727466 test film made of water soluble two polymers, one having high molecular weight and the other having low molecular weight such as hydroxypropyl cellulose, hydroxymethyl propyl cellulose; for detecting chorionic gonadotropin, glucose, prostate specific antigen, metabolites; pesticides; or toxin; monolayer
06/01/2010US7727275 Drug-delivery endovascular stent and method of forming the same
06/01/2010US7727221 Method and device for electrochemical formation of therapeutic species in vivo
06/01/2010CA2509775C Compositions for prevention and treatment of cold and influenza-like symptoms comprising select mucoadhesive polymers
06/01/2010CA2440699C Compounds for treating inflammatory diseases
06/01/2010CA2440680C Steroids as agonists for fxr
06/01/2010CA2431888C Amphiphilic lipid nanoparticles for peptide and/or protein incorporation
06/01/2010CA2428817C Copolyvidone-containing preparation
06/01/2010CA2426625C Combination of fenofibrate and coenzyme q10 for the treatment of endothelial dysfunction
06/01/2010CA2403711C Methods of producing a terminally sterilized topical patch preparation
06/01/2010CA2384064C Vaccine against herpes simplex virus and human papilloma virus
06/01/2010CA2370666C A tenascin-c isoform as a marker for neoplasias
06/01/2010CA2366601C Non-stinging coating composition
06/01/2010CA2353363C Starch- and lactose-based pellets
06/01/2010CA2336879C Sustained-release formulations comprising peptides, polypeptides, proteins or nucleic acids as active ingredients
06/01/2010CA2291851C Stabilized antithrombin iii preparation
06/01/2010CA2221495C Methods and uses for apoptin
06/01/2010CA2219961C Vasopermeability enhancing peptide of human interleukin-2 and immunoconjugates thereof
06/01/2010CA2115839C Hla-restricted hepatitis b virus ctl epitopes
05/2010
05/27/2010WO2010060110A1 Polyvalent rna-nanoparticle compositions
05/27/2010WO2010059963A2 Preparation and methodology of silk fibroin nanoparticles
05/27/2010WO2010059787A1 Therapeutic protein formulations
05/27/2010WO2010059717A2 Formulations comprising ceftiofur and ketoprofen or ceftiofur and benzyl alcohol
05/27/2010WO2010059667A1 Pharmaceutical composition of a potent hcv inhibitor for oral administration
05/27/2010WO2010059565A2 Allografts combined with tissue derived stem cells for bone healing
05/27/2010WO2010059534A2 Directly compressible granular microcrystalline cellulose based excipient, manufacturing process and use thereof
05/27/2010WO2010059135A1 Anti-cancer microparticle
05/27/2010WO2010059001A2 Polymer micelle composition for treatment of resistant cancer cells
05/27/2010WO2010058902A2 Thermosensitive composition preventing tissue adhesion and preparation method thereof
05/27/2010WO2010058853A1 Ceramide dispersion, and process for producing same
05/27/2010WO2010058844A1 Adhesive material containing 5-methyl-1-phenyl-2-(1h)-pyridone
05/27/2010WO2010058669A1 Novel prostaglandin e1 derivative, and nanoparticle having same encapsulated therein
05/27/2010WO2010058427A2 Process for production and purification of polymyxin b sulfate
05/27/2010WO2010058349A1 Pharmaceutical composition for topical application
05/27/2010WO2010058106A1 Novel form of administering osteogenic protein complexes
05/27/2010WO2010057962A2 Crf conjugates with extended half-lives
05/27/2010WO2010057774A1 Site-specific monoconjugated insulinotropic glp-1 peptides
05/27/2010WO2010057624A1 Method for preparing compositions comprising a protein, water and glycerol
05/27/2010WO2010042638A3 Hpma - docetaxel or gemcitabine conjugates and uses therefore
05/27/2010WO2010040051A3 Membrane resident peptide in anti-cancer peptides causes tumor cell necrosis rather than apoptosis of cancer cells
05/27/2010WO2010025322A9 Magnetic nanodelivery of therapeutic agents across the blood brain barrier
05/27/2010WO2010022193A3 Hot-melt extrusion of modified release multi-particulates
05/27/2010WO2010019718A3 Carrier nanoparticles and related compositions, methods and systems
05/27/2010WO2010005480A9 Controlled release compositions of agents that reduce circulating levels of platelets and methods therefor
05/27/2010WO2010003009A3 Synergistic induction of humoral and cellular immunity by combinatorial activation of toll-like receptors
05/27/2010WO2009151627A3 Endosome-disrupting compostions and conjugates
05/27/2010WO2009124941A3 Trypanocidal compounds targeted to trypanosomes interior
05/27/2010WO2009061003A3 Nucleic acid complex and nucleic acid delivery composition
05/27/2010US20100130612 Composition containing chitosan for sustained drug release
05/27/2010US20100130498 Agonists of bitter taste receptors and uses thereof
05/27/2010US20100130478 Sustained release formulations of psychoactive drugs
05/27/2010US20100130427 Polymer-factor viii moiety conjugates
05/27/2010US20100130419 Artery- and Vein-Specific Proteins and Uses Therefor
05/27/2010US20100130401 Protein hydrolysate and plant sterol containing composition for improving serum lipid profile and preventing atheroscleroris
05/27/2010US20100129453 Emulsions comprising rubber arabicum
05/27/2010US20100129395 Hapten-carrier conjugates and uses thereof
05/27/2010US20100126525 Allergen depressant and depression method
05/27/2010CA2781597A1 Pharmaceutical articles coated with lubricious coatings
05/27/2010CA2744207A1 Polyvalent rna-nanoparticle compositions
05/27/2010CA2744150A1 Novel form of administering osteogenic protein complexes
05/27/2010CA2744142A1 Directly compressible granular microcrystalline cellulose based excipient, manufacturing process and use thereof
05/27/2010CA2743869A1 Allografts combined with tissue derived stem cells for bone healing
05/27/2010CA2743551A1 Formulations comprising ceftiofur and ketoprofen or ceftiofur and benzyl alcohol
05/27/2010CA2738732A1 Pharmaceutical composition of a potent hcv inhibitor for oral administration
05/27/2010CA2737045A1 Therapeutic protein formulations
05/27/2010CA2734284A1 Pyrazolone derivative formulations
05/26/2010EP2189476A1 Novel polypeptide and production method thereof
05/26/2010EP2189157A1 EYE DROP COMPRISING DIBENZO[b,e]OXEPIN DERIVATIVE
05/26/2010EP2189154A1 Effervescent tablets and mouth-soluble granulates of S-adenosyl methionine and process for the preparation thereof
05/26/2010EP2188379A1 Complexes of rna and cationic peptides for transfection and for immunostimulation
05/26/2010EP2187974A2 Apparatus to treat and prevent atrial tachyarrhythmias
05/26/2010EP2187973A2 Spore displaying antigens
05/26/2010EP2187971A2 A fold-back diabody diphtheria toxin immunotoxin and methods of use
05/26/2010EP2187970A1 Dissolvable nano web porous film and method of preparing the same
05/26/2010EP2187969A2 High concentration local anesthetic formulations
05/26/2010EP2187968A2 Thermo-kinetic mixing for pharmaceutical applications
05/26/2010EP2187957A2 Selective cytopheresis devices and related methods thereof
05/26/2010EP2187897A1 Composition for preventing virus infection comprising poly-gamma-glutamic acid
05/26/2010EP2187867A1 Injectable pharmaceutical formulation of taxoids
05/26/2010EP2187866A2 Dexamethasone formulations in a biodegradable material
05/26/2010EP2187803A1 Multimodality agents for tumor imaging and therapy
05/26/2010EP2084183B1 Pegylated pth as pth receptor modulators and uses thereof
05/26/2010EP1541155B1 Material for formation of carbon dioxide external preparation
05/26/2010EP1424998B1 Synthesis and use of reagents for improved dna lipofection and/or slow release prodrug and drug therapies
05/26/2010EP1272665B1 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin
05/26/2010CN201481825U cataplasma
05/26/2010CN1985900B Colon-targeting oral compound rubarb preparation
05/26/2010CN1985899B Externally applied medicine for treating burns and scalds
05/26/2010CN1969814B Nasal administered preparation of melatonin
05/26/2010CN1961961B A pharmaceutical formulation and preparation process thereof
05/26/2010CN1960736B Anti-infectious hydrogel compositions
1 ... 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 ... 1712